Accessibility Menu
Ekf Diagnostics Plc logo

Ekf Diagnostics Plc(LSE) EKF

Market Cap£111.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2002)-15%
5 Year-66%
1 Year-12%
1 Month-4%
£0.26
-0.77%
-0.00Today
Ekf Diagnostics Plc last closing stock price
MetricPriceDate
Last closeGBX 25.802026-07-30
Ekf Diagnostics Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.77%GBX 26.002026-07-23
1 month-4.44%GBX 27.002026-06-30
3 month-2.82%GBX 26.552026-05-01
Year to date-2.27%GBX 26.402025-12-31
1 year-11.64%GBX 29.202025-07-30
3 year-3.55%GBX 26.752023-07-31
5 year-65.6%GBX 75.002021-07-30
Since inception-15.46%GBX 0.312002-06-05

Ekf Diagnostics Plc Financials at a Glance

Market Cap

£111.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£101.76M

Net Income (TTM)

£8.36M

EPS (TTM)

£0.00

P/E Ratio

54.89

Dividend

£0.00

Beta (Volatility)

-0.04 (Low)

Price

£0.26

Volume

324,763

Open

£0.25

Previous Close

£0.26

Daily Range

£0.25 - £0.26

52-Week Range

£0.22 - £0.32

Estimated Earnings Date

Sep 22, 2026

EKF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ekf Diagnostics Plc

EKF Diagnostics Holdings plc is an international supplier of diagnostic solutions, specializing in the development and distribution of diagnostic instruments and chemical reagents. Founded in 1990 and based in Cardiff, the company serves a diverse global market, addressing critical diagnostic needs across various healthcare sectors.

Products and Services
  • Hemoglobin analysis devices, including DiaSpect Tm and Hemo Control
  • Advanced glucose and lactate analyzers, such as the Biosen C-Line series
  • Point-of-care solutions for diabetes management, including Quo-Lab A1c and Quo-Test A1c
Growth Outlook
  • Revenue of £26.3 million reported in Q4 2025, showing strong demand
  • Operating income margin of 12.4% indicates efficient cost management
  • Net income of £178,000 in Q4 2025 reflects resilience in challenging markets
Financial Highlights
  • Trailing twelve months (TTM) revenue of £100.5 million demonstrates consistent growth
  • Current ratio of 4.16 indicates strong liquidity position
  • Net profit margin of 4.12% highlights profitability despite market challenges
EKF Diagnostics Holdings plc has established itself as a key player in the medical devices industry, with a robust product portfolio that meets various diagnostic needs. The company's recent financial performance reflects a solid growth trajectory, supported by a strong liquidity position and effective cost management strategies. The diverse range of products and services positions EKF well to capitalize on emerging opportunities in the healthcare sector, making it an intriguing option for potential investors.
AI Generated • Jul 19, 2026

Industry

Healthcare Equipment and Supplies

Employees

301

CEO

Gavin Joseph Jones

Headquarters

Cardiff, CF64 2EZ, GB

EKF Financials

Key Financial Metrics (TTM)

Gross Margin

51.35%

Operating Margin

13.08%

Net Income Margin

4.12%

Return on Equity

3.01%

Return on Capital

9.91%

Return on Assets

2.62%

Earnings Yield

1.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£111.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

430.33M

Volume

324.76K

Avg. Volume

225.86K

Financials (TTM)

Gross Profit

£50.88M

Operating Income

£13.06M

EBITDA

£23.49M

Operating Cash Flow

£23.36M

Capital Expenditure

-£3.78M

Free Cash Flow

£19.59M

Cash & ST Invst.

£15.83M

Total Debt

£1.39M

Ekf Diagnostics Plc Performance Analysis

Ekf Diagnostics Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 66,635,000-18.6%
20232023-12-31GBP 52,611,000-21.0%
20242024-12-31GBP 50,194,000-4.6%
20252025-12-31GBP 51,564,0002.7%
Ekf Diagnostics Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-2.0%
Q42024-12-31-0.9%
Q22025-06-301.0%
Q42025-12-314.3%
Ekf Diagnostics Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.02N/A
20232023-12-31GBP 0.01N/A
20242024-12-31GBP 0.01165.4%
20252025-12-31GBP 0.00-65.9%
Ekf Diagnostics Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-23.3%
Q42024-12-31100.0%
Q22025-06-30-53.3%
Q42025-12-31-90.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£26.33M

+2.3%

Gross Profit

£13.81M

+11.2%

Gross Margin

52.46%

N/A

Market Cap

£111.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£368.86K

N/A

Employees

301

N/A

Net Income

£178.00K

-93.4%

EBITDA

£6.47M

+46.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£15.83M

+104.9%

Total Debt

£1.39M

-66.2%

Accounts Receivable

£6.04M

-29.0%

Inventory

£8.30M

-5.3%

Long Term Debt

£987.00K

+59.7%

Short Term Debt

£398.00K

-88.6%

Return on Assets

2.62%

N/A

Return on Invested Capital

9.15%

N/A

Free Cash Flow

£3.74M

+1095.8%

Operating Cash Flow

£4.79M

+25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DXRX.LDiaceutics PLC
£1.37+3.41%
SCLP.LScancell Holdings plc
£0.10-1.01%
BVXP.LBioventix PLC
£15.10+0.00%
CREO.LCreo Medical Limited
£0.13-2.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.13+0.11%
NVDANvidia
$195.04+0.03%
MSFTMicrosoft
$451.10+0.16%
NOKNokia
$9.09+0.08%

Questions About EKF

What is the current price of Ekf Diagnostics Plc?

Ekf Diagnostics Plc is trading at £0.26 per share.

What is the 52-week range for Ekf Diagnostics Plc?

Over the past 52 weeks, Ekf Diagnostics Plc has traded between £0.22 and £0.32.

How much debt does Ekf Diagnostics Plc have?

As of the most recent reporting period, Ekf Diagnostics Plc reported total debt of £1.39M.

How much cash does Ekf Diagnostics Plc have on hand?

Ekf Diagnostics Plc reported £15.83M in cash and cash equivalents in its most recent financial results.

What is Ekf Diagnostics Plc’s dividend yield?

Ekf Diagnostics Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.